Literature DB >> 2157090

Duration of mouse hepatitis virus infection: studies in immunocompetent and chemically immunosuppressed mice.

S W Barthold1, A L Smith.   

Abstract

The duration of mouse hepatitis virus (MHV) infection was examined in mice inoculated intranasally with selected strains of MHV. Following inoculation with virulent MHV-JHM, genetically susceptible BALB/c mice and resistant CD1 mice had detectable virus in the brain at 1 month, but not later intervals up to 12 months. BALB/c mice infected with avirulent MHV-S or MHV-1 had no detectable virus in brains at 1 month or thereafter. Immunosuppression of BALB/c mice with treatment regimens of hydrocortisone acetate or cyclophosphamide at 1 and 2 months after infection with MHV-JHM did not activate detectable virus in liver or increase the prevalence or degree of brain infection. Immunosuppression with these drugs during the acute phase of MHV-JHM infection influenced MHV infection, based on virus quantification in livers, but timing of drug treatment relative to MHV infection was critical. Mice infected with MHV developed IgG serum antibody titers that persisted without decline for up to 1 year after infection. Antibody titers varied with mouse genotype and infecting virus. These studies, using intranasal inoculation, support the conclusions of others, using other routes of inoculation, that MHV infection is not persistent in adult, immunocompetent mice.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157090

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  7 in total

1.  Cytokine induction during T-cell-mediated clearance of mouse hepatitis virus from neurons in vivo.

Authors:  B D Pearce; M V Hobbs; T S McGraw; M J Buchmeier
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

2.  DNA rearrangement causes hepatocarcinogenesis in albumin-plasminogen activator transgenic mice.

Authors:  E P Sandgren; R D Palmiter; J L Heckel; R L Brinster; J L Degen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

3.  Interference of natural mouse hepatitis virus infection with cytokine production and susceptibility to Trypanosoma cruzi.

Authors:  A C Torrecilhas; E Faquim-Mauro; A V Da Silva; I A Abrahamsohn
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

4.  Transmission of mouse minute virus (MMV) but not mouse hepatitis virus (MHV) following embryo transfer with experimentally exposed in vivo-derived embryos.

Authors:  Esther Mahabir; Diana Bulian; Jeffrey Needham; Anna Mayer; Bart Mateusen; Ann Van Soom; Hans Nauwynck; Jörg Schmidt
Journal:  Biol Reprod       Date:  2006-10-04       Impact factor: 4.285

Review 5.  Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2.

Authors:  Robert W Körner; Mohamed Majjouti; Miguel A Alejandre Alcazar; Esther Mahabir
Journal:  Viruses       Date:  2020-08-12       Impact factor: 5.048

Review 6.  Microbial considerations in genetically engineered mouse research.

Authors:  Craig L Franklin
Journal:  ILAR J       Date:  2006

7.  Sequence analysis of the nucleoprotein genes of three enterotropic strains of murine coronavirus.

Authors:  F R Homberger
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.